Arrowstreet Capital’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-522,191
Closed -$23.1M 1913
2025
Q4
$23.1M Sell
522,191
-651,469
-56% -$36.6M 0.01% 699
2025
Q3
$85.9M Sell
1,173,660
-62,607
-5% -$4.08M 0.05% 324
2025
Q2
$75.8M Sell
1,236,267
-365,623
-23% -$20.4M 0.05% 322
2025
Q1
$93M Buy
1,601,890
+91,474
+6% +$5.78M 0.08% 241
2024
Q4
$80.6M Buy
1,510,416
+1,323,634
+709% +$64.8M 0.06% 263
2024
Q3
$8.14M Buy
+186,782
New +$6.23M 0.01% 816
2022
Q1
Sell
-36,932
Closed -$1.85M 1270
2021
Q4
$1.85M Buy
+36,932
New +$2.4M ﹤0.01% 1034

Other funds holding DOCS

Arrowstreet Capital's DOCS Position: Q1 2026 in Review

Arrowstreet Capital sold out of Doximity (DOCS) in Q1 2026, closing a stake of 522,191 shares — an estimated $23.1M sold.

Arrowstreet Capital first reported a position in DOCS in Q4 2021 and held it in 7 quarters. The position peaked at $93M in Q1 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Arrowstreet Capital reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 522,191 Doximity shares in Q1 2026, an estimated $23.1M.
  • Arrowstreet Capital first reported a position in Doximity in Q4 2021 and held it in 7 quarters.
  • Arrowstreet Capital's Doximity position peaked at $93M in Q1 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.